Convatec Group PLC (LON:CTEC)
London · Delayed Price · Currency is GBP · Price in GBX 226.00
+0.40 (0.18%)
Aug 21, 2026, 4:54 PM GMT
Convatec Group Market Cap
Convatec Group has a market cap or net worth of 4.42 billion as of August 21, 2026. Its market cap has decreased by -11.52% in one year.
Market Cap
4.42B
Enterprise Value
5.66B
Revenue
1.88B
Ranking
n/a
PE Ratio
48.39
Stock Price
226.00
ChartMarket Cap Chart
Since October 26, 2016, Convatec Group's market cap has increased from 4.39B to 4.42B, an increase of 0.60%. That is a compound annual growth rate of 0.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 4.42B | -6.83% |
| Dec 31, 2025 | 4.74B | 4.77% |
| Dec 31, 2024 | 4.53B | -9.11% |
| Dec 29, 2023 | 4.98B | 4.77% |
| Dec 30, 2022 | 4.75B | 22.28% |
| Dec 31, 2021 | 3.89B | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 183.11B |
| GSK plc | 75.65B |
| Haleon | 31.32B |
| Smith & Nephew | 9.34B |
| Hikma Pharmaceuticals | 3.48B |
| HUTCHMED (China) | 1.64B |
| Genus | 1.52B |
| Oxford Nanopore Technologies | 1.19B |